Albert David is currently trading at Rs. 314.20, up by 20.90 points or 7.13% from its previous closing of Rs. 293.30 on the BSE.
The scrip opened at Rs. 301.50 and has touched a high and low of Rs. 320.90 and Rs. 301.50 respectively. So far 17,000 shares were traded on the counter.
The BSE group 'XC' stock of face value Rs. 10 has touched a 52 week high of Rs. 436.50 on 01-Dec-2015 and a 52 week low of Rs. 238.20 on 17-Feb-2016.
Last one week high and low of the scrip stood at Rs. 320.90 and Rs. 271.00 respectively. The current market cap of the company is Rs. 179.32 crore.
The promoters holding in the company stood at 60.90% while Institutions and Non-Institutions held 4.55% and 34.55% respectively.
Albert David (ADL) has entered into agreements with Zydus Healthcare (a wholly owned subsidiary of Cadila Healthcare) for the sale of ADL’s brand ‘Actibile’ with a free and marketable title along with all business information, know-how and the trademarks associated with the brand in territories of the Union of India; Nepal, South America (excluding Peru and Colombia), The United States of America; Japan, South Africa; the European Union; and East Europe, for a lump sum consideration of Rs 55.00 crore.
The transaction is a part of strategic initiative by Albert David and the proceeds front the sale will be invested for growth and expansion of the branded formulation business of the company.
Albert David manufactures pharmaceutical formulations and bulk drugs, infusion solutions and oral solids, disposable syringes and needles and herbal formulations.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: